Cystic fibrosis (CF ... pathogens varies with age. Treatment of infectious pulmonary exacerbations utilizes combinations of oral, inhaled and intravenous antibiotic agents. Chronic use of ...

Expert Rev Resp Med. 2008;2(4):479-487. Treatment of chronic cystic fibrosis (CF) lung infection with inhaled antibiotics for site-specific drug delivery allows concentrated drug therapy to the ...

When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

How are modern day chemists seeking to treat cystic fibrosis? Join Peter Grootenhuis of Vertex Pharmaceuticals as he delivers a brief overview of the drug discovery approaches and challenges to ...

This article gives an overview of the medications for cystic fibrosis. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators ... are many types of antibiotics that someone with ...

Glox Therapeutics secures £500K from a £3M fund to develop antibiotics targeting antimicrobial-resistant lung infections in ...

Collaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate ...

Cystic fibrosis (CF) is a genetic disorder ... as it is often resistant to many conventional antibiotics and can complicate treatment regimens. Recent research has focused on understanding the ...

About Cystic Fibrosis ... lifelong treatment with multiple daily medications. The complications of the disease result in progressive loss of lung function, increasing need for IV antibiotics ...

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...

The company can gain expert guidance and resources, accelerating the development of treatments for CF ... "Glox to develop precision antibiotics for cystic fibrosis" was originally created and ...